Tapewire

Nasdaq · USD

LNTH

Lantheus Holdings, Inc.

Export transactions ↓
Tapewire entity
690
SEC CIK
0001521036
Parsed reports
534

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 03, 2019 Filed Sep 5, 2019 20:30 UTC
Heino Mary AnneDirector · President & CEO
SaleCommon Stock 25,538 $21.21 $541,678.86
Disclosure

SEC source: 0000899243-19-022833 · doc4.xml · nonDerivative · entry 1

Heino Mary Anne · CIK 0001610676 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 597,884

F1 · kind: Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions under 10b5-1 plans. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2019, to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.84 to $21.54, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
July 10, 2019 Filed Jul 12, 2019 16:05 UTC SaleCommon Stock 4,918 $28.07 $138,048.26
Disclosure

SEC source: 0000899243-19-019527 · doc4.xml · nonDerivative · entry 1

MARKISON BRIAN A · CIK 0001283061 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,549

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.07 to $28.15, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc. ("LNTH"), any security holder of LNTH or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
July 10, 2019 Filed Jul 12, 2019 16:13 UTC
DUFFY MICHAEL PSVP and General Counsel
SaleCommon Stock 8,819 $28.14 $248,166.66
Disclosure

SEC source: 0000899243-19-019536 · doc4.xml · nonDerivative · entry 1

DUFFY MICHAEL P · CIK 0001237200 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,494

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2019.

Read SEC document
July 08, 2019 Filed Jul 10, 2019 20:05 UTC
Orlandi CesareChief Medical Officer
Exercise / conversionStock Option (right to buy) · Derivative 8,896 $0.00 Strike: $18.66 $0.00
Disclosure

SEC source: 0000899243-19-019423 · doc4.xml · derivative · entry 10

Orlandi Cesare · CIK 0001610664 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,896 shares

Expires 2023-08-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019.

F6 · derivative.exercise_date: These options vested in four equal installments on August 5, 2014, 2015, 2016 and 2017.

Read SEC document
July 08, 2019 Filed Jul 10, 2019 20:05 UTC
Orlandi CesareChief Medical Officer
Exercise / conversionStock Option (right to buy) · Derivative 6,672 $0.00 Strike: $21.10 $0.00
Disclosure

SEC source: 0000899243-19-019423 · doc4.xml · derivative · entry 9

Orlandi Cesare · CIK 0001610664 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,672 shares

Expires 2023-03-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019.

F5 · derivative.exercise_date: Options to purchase 13,345 shares of Common Stock were granted to the reporting person on March 4, 2013, which options were subject to vesting in up to four equal annual installments based upon the level of LNTH's satisfaction of certain performance criteria for each of fiscal years 2013, 2014, 2015 and 2016. A certain level of the performance criteria were satisfied for each of fiscal years 2013 and 2014, resulting in the partial vesting as to 6,672 shares of Common Stock.

Read SEC document
July 08, 2019 Filed Jul 10, 2019 20:05 UTC
Orlandi CesareChief Medical Officer
Exercise / conversionStock Option (right to buy) · Derivative 13,346 $0.00 Strike: $21.10 $0.00
Disclosure

SEC source: 0000899243-19-019423 · doc4.xml · derivative · entry 8

Orlandi Cesare · CIK 0001610664 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,346 shares

Expires 2023-03-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019.

F4 · derivative.exercise_date: These options vested in four equal installments on March 4, 2014, 2015, 2016 and 2017.

Read SEC document
July 08, 2019 Filed Jul 10, 2019 20:05 UTC
Orlandi CesareChief Medical Officer
Exercise / conversionStock Option (right to buy) · Derivative 6,672 $0.00 Strike: $21.10 $0.00
Disclosure

SEC source: 0000899243-19-019423 · doc4.xml · derivative · entry 7

Orlandi Cesare · CIK 0001610664 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,672 shares

Expires 2023-03-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019.

Read SEC document
July 08, 2019 Filed Jul 10, 2019 20:05 UTC
Orlandi CesareChief Medical Officer
SaleCommon Stock 7,584 $27.60 $209,318.40
Disclosure

SEC source: 0000899243-19-019423 · doc4.xml · nonDerivative · entry 6

Orlandi Cesare · CIK 0001610664 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,483

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.06 to $27.99, inclusive. The reporting person undertakes to provide to LNTH, any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Read SEC document
July 08, 2019 Filed Jul 10, 2019 20:05 UTC
Orlandi CesareChief Medical Officer
SaleCommon Stock 28,002 $28.33 $793,296.66
Disclosure

SEC source: 0000899243-19-019423 · doc4.xml · nonDerivative · entry 5

Orlandi Cesare · CIK 0001610664 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,067

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.45, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc. ("LNTH"), any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
July 08, 2019 Filed Jul 10, 2019 20:05 UTC
Orlandi CesareChief Medical Officer
Exercise / conversionCommon Stock 8,896 $21.10 $187,705.60
Disclosure

SEC source: 0000899243-19-019423 · doc4.xml · nonDerivative · entry 4

Orlandi Cesare · CIK 0001610664 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,069

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019.

Read SEC document
July 08, 2019 Filed Jul 10, 2019 20:05 UTC
Orlandi CesareChief Medical Officer
Exercise / conversionCommon Stock 6,672 $21.10 $140,779.20
Disclosure

SEC source: 0000899243-19-019423 · doc4.xml · nonDerivative · entry 3

Orlandi Cesare · CIK 0001610664 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,173

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019.

Read SEC document
July 08, 2019 Filed Jul 10, 2019 20:05 UTC
Orlandi CesareChief Medical Officer
Exercise / conversionCommon Stock 13,346 $21.10 $281,600.60
Disclosure

SEC source: 0000899243-19-019423 · doc4.xml · nonDerivative · entry 2

Orlandi Cesare · CIK 0001610664 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,501

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019.

Read SEC document
July 08, 2019 Filed Jul 10, 2019 20:05 UTC
Orlandi CesareChief Medical Officer
Exercise / conversionCommon Stock 6,672 $21.10 $140,779.20
Disclosure

SEC source: 0000899243-19-019423 · doc4.xml · nonDerivative · entry 1

Orlandi Cesare · CIK 0001610664 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,155

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019.

Read SEC document
July 03, 2019 Filed Jul 5, 2019 16:05 UTC SaleCommon Stock 5,000 $28.41 $142,050.00
Disclosure

SEC source: 0000899243-19-019244 · doc4.xml · nonDerivative · entry 1

MARKISON BRIAN A · CIK 0001283061 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,467

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019.

Read SEC document
June 26, 2019 Filed Jun 28, 2019 16:30 UTC SaleCommon Stock 5,000 $27.67 $138,361.00
Disclosure

SEC source: 0000899243-19-018534 · doc4.xml · nonDerivative · entry 1

MARKISON BRIAN A · CIK 0001283061 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,467

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.62 to $27.81, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
June 20, 2019 Filed Jun 24, 2019 20:30 UTC
Heino Mary AnneDirector · President & CEO
SaleCommon Stock 1,575 $28.48 $44,856.00
Disclosure

SEC source: 0000899243-19-017934 · doc4.xml · nonDerivative · entry 2

Heino Mary Anne · CIK 0001610676 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 623,422

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2019.

Read SEC document
June 20, 2019 Filed Jun 24, 2019 20:30 UTC
Heino Mary AnneDirector · President & CEO
SaleCommon Stock 12,765 $27.82 $355,078.90
Disclosure

SEC source: 0000899243-19-017934 · doc4.xml · nonDerivative · entry 1

Heino Mary Anne · CIK 0001610676 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 624,997

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.385 to $28.32, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
June 19, 2019 Filed Jun 20, 2019 20:32 UTC
Bolla John J.Chief Operations Officer
SaleCommon Stock 128 $27.32 $3,496.96
Disclosure

SEC source: 0000899243-19-017656 · doc4.xml · nonDerivative · entry 2

Bolla John J. · CIK 0001741843 · Chief Operations Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,027

F1 · kind: Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2018, to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4.

Read SEC document
June 19, 2019 Filed Jun 21, 2019 16:30 UTC SaleCommon Stock 5,000 $27.40 $137,014.50
Disclosure

SEC source: 0000899243-19-017814 · doc4.xml · nonDerivative · entry 1

MARKISON BRIAN A · CIK 0001283061 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,467

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.40 to $27.43, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:32 UTC
Bolla John J.Chief Operations Officer
SaleCommon Stock 1,619 $27.58 $44,652.02
Disclosure

SEC source: 0000899243-19-017656 · doc4.xml · nonDerivative · entry 1

Bolla John J. · CIK 0001741843 · Chief Operations Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,155

F1 · kind: Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2018, to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4.

Read SEC document
June 18, 2019 Filed Jun 27, 2019 20:38 UTC Amendment
Bolla John J.Chief Operations Officer
SaleCommon Stock 2,241 $27.58 $61,806.78
Disclosure

SEC source: 0000899243-19-018377 · doc4a.xml · nonDerivative · entry 1

Bolla John J. · CIK 0001741843 · Chief Operations Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,405

F1 · kind: Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4

F2 · shares: The Form 4 originally filed on June 20, 2019 inadvertently reported 1,619 shares disposed on June 18, 2019. The correct amount of shares disposed on June 18, 2019, is 2,241 and is being reported in this amendment.

F3 · balance_after: The number of shares beneficially owned is being updated to reflect the correct number beneficially owned, after giving effect to the transaction on June 19, 2019 previously reported on the original Form 4.

Read SEC document
June 12, 2019 Filed Jun 14, 2019 16:30 UTC SaleCommon Stock 5,000 $25.27 $126,365.00
Disclosure

SEC source: 0000899243-19-017062 · doc4.xml · nonDerivative · entry 1

MARKISON BRIAN A · CIK 0001283061 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,467

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.18 to $25.30, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
June 07, 2019 Filed Jun 11, 2019 16:32 UTC
LENO SAM RDirector
SaleCommon Stock 3,950 $25.33 $100,059.43
Disclosure

SEC source: 0000899243-19-016392 · doc4.xml · nonDerivative · entry 1

LENO SAM R · CIK 0001238660 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,580

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.12 to $25.70, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
June 05, 2019 Filed Jun 7, 2019 16:30 UTC SaleCommon Stock 10,000 $24.71 $247,127.00
Disclosure

SEC source: 0000899243-19-016022 · doc4.xml · nonDerivative · entry 1

SCHAFFER DERACE L · CIK 0001031735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,994

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.36 to $24.84, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
June 05, 2019 Filed Jun 7, 2019 16:30 UTC SaleCommon Stock 5,000 $24.60 $123,009.50
Disclosure

SEC source: 0000899243-19-016021 · doc4.xml · nonDerivative · entry 1

MARKISON BRIAN A · CIK 0001283061 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,467

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.43 to $24.825, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
June 04, 2019 Filed Jun 5, 2019 16:30 UTC SaleCommon Stock 1,080 $24.61 $26,578.15
Disclosure

SEC source: 0000899243-19-015598 · doc4.xml · nonDerivative · entry 3

SCHAFFER DERACE L · CIK 0001031735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,994

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2019.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.59 to $24.65 , inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.

Read SEC document
June 04, 2019 Filed Jun 5, 2019 16:30 UTC SaleCommon Stock 8,920 $24.11 $215,080.82
Disclosure

SEC source: 0000899243-19-015598 · doc4.xml · nonDerivative · entry 2

SCHAFFER DERACE L · CIK 0001031735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,074

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2019.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.59 to $24.58 , inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Read SEC document
June 03, 2019 Filed Jun 5, 2019 16:30 UTC SaleCommon Stock 10,000 $23.47 $234,725.00
Disclosure

SEC source: 0000899243-19-015598 · doc4.xml · nonDerivative · entry 1

SCHAFFER DERACE L · CIK 0001031735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,994

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.25 to $23.78, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
May 29, 2019 Filed May 31, 2019 16:30 UTC SaleCommon Stock 5,000 $24.29 $121,453.50
Disclosure

SEC source: 0000899243-19-015291 · doc4.xml · nonDerivative · entry 1

MARKISON BRIAN A · CIK 0001283061 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,467

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.25 to $24.41, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
May 22, 2019 Filed May 24, 2019 16:30 UTC SaleCommon Stock 5,000 $24.73 $123,627.50
Disclosure

SEC source: 0000899243-19-014739 · doc4.xml · nonDerivative · entry 1

MARKISON BRIAN A · CIK 0001283061 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,467

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.65 to $24.785, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
May 20, 2019 Filed May 22, 2019 20:30 UTC
Heino Mary AnneDirector · President & CEO
SaleCommon Stock 16,827 $23.89 $401,939.82
Disclosure

SEC source: 0000899243-19-014346 · doc4.xml · nonDerivative · entry 1

Heino Mary Anne · CIK 0001610676 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 637,762

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.66 to $24, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
May 15, 2019 Filed May 17, 2019 16:31 UTC SaleCommon Stock 5,000 $24.75 $123,754.50
Disclosure

SEC source: 0000899243-19-014003 · doc4.xml · nonDerivative · entry 1

MARKISON BRIAN A · CIK 0001283061 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,467

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.75 to $24.765, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
May 08, 2019 Filed May 10, 2019 16:31 UTC SaleCommon Stock 5,000 $25.22 $126,115.50
Disclosure

SEC source: 0000899243-19-013046 · doc4.xml · nonDerivative · entry 1

MARKISON BRIAN A · CIK 0001283061 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,467

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.20 to $25.27, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
May 01, 2019 Filed May 2, 2019 16:30 UTC SaleCommon Stock 5,000 $23.91 $119,537.00
Disclosure

SEC source: 0000899243-19-011782 · doc4.xml · nonDerivative · entry 2

MARKISON BRIAN A · CIK 0001283061 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,467

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.815 to $24.13, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Read SEC document
April 30, 2019 Filed May 2, 2019 16:30 UTC SaleCommon Stock 5,000 $24.30 $121,519.00
Disclosure

SEC source: 0000899243-19-011782 · doc4.xml · nonDerivative · entry 1

MARKISON BRIAN A · CIK 0001283061 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,467

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.25 to $24.35, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
April 29, 2019 Filed May 1, 2019 16:30 UTC
DUFFY MICHAEL PSee Remarks
SaleCommon Stock 6,908 $24.84 $171,615.44
Disclosure

SEC source: 0000899243-19-011589 · doc4.xml · nonDerivative · entry 1

DUFFY MICHAEL P · CIK 0001237200 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,313

F1 · kind: Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4.

Read SEC document
April 29, 2019 Filed May 1, 2019 20:30 UTC
Orlandi CesareChief Medical Officer
SaleCommon Stock 11,250 $24.85 $279,616.50
Disclosure

SEC source: 0000899243-19-011590 · doc4.xml · nonDerivative · entry 1

Orlandi Cesare · CIK 0001610664 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,483

F1 · kind: Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions under 10b5-1 plans. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2018, in part, to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.37 to $25.23, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
April 26, 2019 Filed Apr 30, 2019 20:30 UTC
Heino Mary AnneDirector · President & CEO
SaleCommon Stock 29,813 $24.86 $741,073.67
Disclosure

SEC source: 0000899243-19-011444 · doc4.xml · nonDerivative · entry 1

Heino Mary Anne · CIK 0001610676 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 654,589

F1 · kind: Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions under 10b5-1 plans. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2019, to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.51 to $25.22, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
April 23, 2019 Filed Apr 25, 2019 16:30 UTC SaleCommon Stock 5,000 $24.07 $120,368.00
Disclosure

SEC source: 0000899243-19-011133 · doc4.xml · nonDerivative · entry 1

MARKISON BRIAN A · CIK 0001283061 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,467

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.11, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
April 16, 2019 Filed Apr 18, 2019 16:30 UTC SaleCommon Stock 5,000 $25.26 $126,297.50
Disclosure

SEC source: 0000899243-19-010897 · doc4.xml · nonDerivative · entry 1

MARKISON BRIAN A · CIK 0001283061 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,467

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.25 to $25.40, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
April 12, 2019 Filed Apr 16, 2019 20:30 UTC
Heino Mary AnneDirector · President & CEO
SaleCommon Stock 15,799 $25.40 $401,316.72
Disclosure

SEC source: 0000899243-19-010687 · doc4.xml · nonDerivative · entry 1

Heino Mary Anne · CIK 0001610676 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 684,402

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.07 to $25.66, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 16:30 UTC SaleCommon Stock 10,000 $24.41 $244,094.00
Disclosure

SEC source: 0000899243-19-009765 · doc4.xml · nonDerivative · entry 1

SCHAFFER DERACE L · CIK 0001031735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,994

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.11 to $25.00, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
March 06, 2019 Filed Mar 8, 2019 16:32 UTC SaleCommon Stock 3,192 $22.77 $72,672.26
Disclosure

SEC source: 0000899243-19-006914 · doc4.xml · nonDerivative · entry 1

Pruden Gary J · CIK 0001673416 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,072

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2018.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.58 to $23.01, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
March 06, 2019 Filed Mar 8, 2019 21:33 UTC
McHugh JulieDirector
SaleCommon Stock 2,595 $22.77 $59,075.18
Disclosure

SEC source: 0000899243-19-006915 · doc4.xml · nonDerivative · entry 1

McHugh Julie · CIK 0001487179 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,510

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2018.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.57 to $23.01, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
March 06, 2019 Filed Mar 8, 2019 16:32 UTC SaleCommon Stock 3,500 $22.78 $79,723.00
Disclosure

SEC source: 0000899243-19-006912 · doc4.xml · nonDerivative · entry 1

Thrall James H · CIK 0001315048 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,764

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2018.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.58 to $23.02, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
March 06, 2019 Filed Mar 8, 2019 16:32 UTC
DUFFY MICHAEL PSee Remarks
SaleCommon Stock 1,789 $22.77 $40,733.74
Disclosure

SEC source: 0000899243-19-006913 · doc4.xml · nonDerivative · entry 1

DUFFY MICHAEL P · CIK 0001237200 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,221

F1 · kind: Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions under 10b5-1 plans. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2018, to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.58 to $23.04, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
March 06, 2019 Filed Mar 8, 2019 16:30 UTC SaleCommon Stock 3,932 $22.77 $89,535.57
Disclosure

SEC source: 0000899243-19-006908 · doc4.xml · nonDerivative · entry 1

Robertson A Frederick · CIK 0001396084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,062

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2018.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.57 to $23.02, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
March 06, 2019 Filed Mar 8, 2019 21:35 UTC
Orlandi CesareChief Medical Officer
SaleCommon Stock 4,271 $22.77 $97,237.86
Disclosure

SEC source: 0000899243-19-006916 · doc4.xml · nonDerivative · entry 1

Orlandi Cesare · CIK 0001610664 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,733

F1 · kind: Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions under 10b5-1 plans. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2018, in part, to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.57 to $23.02, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
March 05, 2019 Filed Mar 6, 2019 21:30 UTC
Heino Mary AnneDirector · President & CEO
SaleCommon Stock 9,019 $23.34 $210,482.72
Disclosure

SEC source: 0000899243-19-006444 · doc4.xml · nonDerivative · entry 2

Heino Mary Anne · CIK 0001610676 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 700,201

F1 · kind: Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions under 10b5-1 plans. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2018, to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.05 to $23.80, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
March 04, 2019 Filed Mar 6, 2019 21:30 UTC
Heino Mary AnneDirector · President & CEO
SaleCommon Stock 275 $23.68 $6,511.84
Disclosure

SEC source: 0000899243-19-006444 · doc4.xml · nonDerivative · entry 1

Heino Mary Anne · CIK 0001610676 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 709,220

F1 · kind: Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions under 10b5-1 plans. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2018, to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.